Ex-Allergan leader joins BioMarin board; Ex-FDA official Dr. Goodman joins GSK board; Dr. Reddy's relaunches generic Nexium in a new color;

> Former Allergan CEO David Pyott has joined BioMarin's board of directors. Report

> GlaxoSmithKline has named former FDA chief scientist Dr. Jesse Goodman to its board of directors. Release

> NHS has decided to return to its original recommendation that Merck's Ezetrol (Zetia) be used for treating primary hypercholesterolemia in some adults. Story

> Dr. Reddy's Laboratories has relaunched its generic version of AstraZeneca heartburn med Nexium after a U.S. court made it stop using the color purple. Story

Suggested Articles

Novartis said it plans to use the complete response rate data for a U.S. filing in follicular lymphoma in 2021.

Sen. Elizabeth Warren asked the SEC to probe Kodak trades made before the Trump administration unveiled their drug supply deal—and $765M in funding.

Amarin's wild 2020 ride continues with plans to launch its cardiovascular med Vascepa in Europe without a bigger marketing partner.